Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K7KM
|
||||
Former ID |
DNC005001
|
||||
Drug Name |
3-Phenyl-1-(2-methylthiazol-4-ylethynyl)benzene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530140] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H13NS
|
||||
Canonical SMILES |
CC1=NC(=CS1)C#CC2=CC(=CC=C2)C3=CC=CC=C3
|
||||
InChI |
1S/C18H13NS/c1-14-19-18(13-20-14)11-10-15-6-5-9-17(12-15)16-7-3-2-4-8-16/h2-9,12-13H,1H3
|
||||
InChIKey |
JWWDWRFQBGXCEK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor 5 | Target Info | Inhibitor | [530140] | |
References | |||||
Ref 530140 | J Med Chem. 2009 Jun 11;52(11):3563-75.Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists. | ||||
Ref 530140 | J Med Chem. 2009 Jun 11;52(11):3563-75.Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.